When the Vaccine Covid-19 race begins, the medical authorities have known that poor countries will not be able to compete with rich countries.
However, not many people predict the perspective of poor water to depend on the source of vaccines sponsored from rich countries, or the inequality inequality of the vaccine will be in a bad level and exist too today.
The cause of so large vaccine holes is thought to be derived from the first orientation in the development and distribution of vaccines.
For many years, USA, Europe and India have been highly appreciated by the World Health Organization (WHO) in the level of availability of responding to a pandemic.
When Covid-19 came, these assessments suddenly became too optimistic, in the context of the United States and European countries suffer from the severe influence from the beginning.
Nurses prepare a dose of Vaccine Covid-19 at the vaccination point in Foxborough, Massachusetts, USA, on May 19.
On May 15, 2020, US President Donald Trump launched a speedy campaign and pledged to have Vaccine Covid-19 before the new year.
The Speed Campaign seems to have motivated the vaccine race in the world, with the US and the UK in the lead position.
In order to prevent vaccination inequality, the Covax initiative was born under the leadership of WHO, CEPI and the Global Vaccine and Global Vaccination (GAVI), to ensure all countries have access to Vaccine Covid-19
Costa Rica and WHO have cooperated to provide a plan for a technology sharing platform, to expand the production of vaccines.
In the US, the production and testing process of vaccine was carried out in parallel, while the European Union (EU) and he also expanded production scale.
On December 8, 2020, he became the first country to start the mass vaccination campaign, 6 days later to the United States.
On February 24, Covax delivered the first vaccine to Ghana, including 600,000 doses of Astrazeneca produced in India, the main supplier for the program.
Astrazeneca repeatedly announces delay delivery to the EU.
A recent meeting among WHO's VACCINE distribution team members ended without achieving any results, because there are no vaccines to allocate.
Covax must now rely on uncertain funding vaccines, with most commitments to last until 2022. Dr. Ingrid Katz, researcher at the Global Health Center of Massachusetts General Hospital of America, giving
Meanwhile, Strive Masiyiwa, envoys in charge of the African Union's vaccine negotiation, comparing the current situation with hunger that the richest people bought the bakery.
The vaccine difference is inevitable, when taxpayers in rich countries are also expected to pay.
This is the same problem what we have faced in HIV pandemic.